Cargando…

Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis

INTRODUCTION: Previous studies have reported a close relationship between cancer and microbes, particularly gut and tumor microbiota; however, the presence of tumor microbiome in nasopharyngeal carcinoma (NPC) and its role in the prognosis of NPC remain unclear. METHODS: We collected 64 samples incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Guihua, Wei, Wei, Liao, Wei, Wang, Rong, Peng, Yingpeng, Zhou, Yuling, Huang, Xiaotao, Xian, Shiping, Peng, Shunli, Zhang, Zhaoyuan, Feng, Shaoyan, Liu, Ye, Hong, Haiyu, Xia, Yunfei, Yan, Yan, Liu, Qiaodan, Liu, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168217/ https://www.ncbi.nlm.nih.gov/pubmed/35677160 http://dx.doi.org/10.3389/fonc.2022.859721

Ejemplares similares

Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial
por: Huang, Xiaotao, et al.
Publicado: (2022)

Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma
por: Liu, Qiaodan, et al.
Publicado: (2023)

Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe
por: Deng, Zhaoming, et al.
Publicado: (2021)

Treatment of Locally Advanced Nasopharyngeal Carcinoma by Helical Tomotherapy: An Observational, Prospective Analysis
por: Liu, Zhigang, et al.
Publicado: (2019)

Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin
por: Liang, Xuexia, et al.
Publicado: (2022)

The Oral Microbiome as Mediator between Oral Hygiene and Its Impact on Nasopharyngeal Carcinoma
por: Liu, Qiao-Yun, et al.
Publicado: (2023)

CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma
por: Chen, Lin, et al.
Publicado: (2021)

Long non-coding RNA SPRY4-IT1 promotes proliferation and metastasis in nasopharyngeal carcinoma cell
por: Li, Yanfei, et al.
Publicado: (2022)

Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma
por: Wei, Gan-Bao, et al.
Publicado: (2016)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

Decreased P27 protein expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma
por: Jiang, Qingping, et al.
Publicado: (2013)

Favorable prognosis of female patients with nasopharyngeal carcinoma
por: Lu, Xing, et al.
Publicado: (2013)

High expression of p300 is linked to aggressive features and poor prognosis of Nasopharyngeal Carcinoma
por: Liao, Zhi-Wei, et al.
Publicado: (2012)

RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma
por: Qu, Chen, et al.
Publicado: (2017)

Involvement of KLRK1 in immune infiltration of head and neck squamous cell carcinoma correlates with favorable prognosis
por: Tan, Haosheng, et al.
Publicado: (2023)

Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma
por: Wu, Xiwen, et al.
Publicado: (2021)

Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19
por: Liu, Jing, et al.
Publicado: (2021)

A Meta-Analysis of Vascular Endothelial Growth Factor for Nasopharyngeal Cancer Prognosis
por: Wang, Feng, et al.
Publicado: (2018)

Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients
por: Wang, Ya-Qin, et al.
Publicado: (2021)

Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model
por: Liu, Wei, et al.
Publicado: (2021)

CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis
por: Tu, Ziwei, et al.
Publicado: (2016)

The human oral – nasopharynx microbiome as a risk screening tool for nasopharyngeal carcinoma
por: Hao, Yu, et al.
Publicado: (2022)

Gut Microbiome Distinguishes Patients With Epilepsy From Healthy Individuals
por: Cui, Guangying, et al.
Publicado: (2022)

The nasopharyngeal microbiome and LRTIs in infants
por: Rogers, Geraint B
Publicado: (2019)

The nasopharyngeal microbiome in COVID-19
por: Candel, Sergio, et al.
Publicado: (2023)

The four-microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients
por: Zhang, Siwei, et al.
Publicado: (2019)

High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma
por: Xu, Ya-Fei, et al.
Publicado: (2015)

Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma
por: Tian, Yun-Ming, et al.
Publicado: (2015)

Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma
por: Lin, Tao-Yan, et al.
Publicado: (2019)

Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
por: Liao, Lie-Qiang, et al.
Publicado: (2016)

Nutritional intervention for the prognosis of nasopharyngeal carcinoma chemoradiotherapy patients: A meta-analysis
por: He, Ying, et al.
Publicado: (2023)

Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study
por: Zhang, Peng, et al.
Publicado: (2017)

p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study
por: ZHANG, PENG, et al.
Publicado: (2015)

Encouraging efficacy of a comprehensive therapy consisting of sintilimab, bevacizumab biosimilar IBI305, hypo-fractionated intensity-modulated radiotherapy, and oxaliplatin for a maxillary metastasis from hepatocellular carcinoma: A case report and literature review
por: Liang, Xuexia, et al.
Publicado: (2022)

Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma
por: Cui, Linchong, et al.
Publicado: (2023)

Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma
por: Dong, Dan-Ning, et al.
Publicado: (2021)

Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma
por: Yu, Ying, et al.
Publicado: (2020)

Potential Associations Between Microbiome and COVID-19
por: Wang, Huifen, et al.
Publicado: (2021)

Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis
por: Liao, Kuang-Ming, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mgjidqg9p5lk0n6tl84mnpmsv4